SCHEMBL23473659

SCHEMBL23473659

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4oc5cccc(-c6ccc7sc(-c8ccccc8)nc7c6)c5c4c3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.40
▸ RAB9A P51151 8/20 0.40
▸ NFKB1 P19838 7/20 0.40
▸ NFKB2 Q00653 7/20 0.40
▸ RELA Q04206 7/20 0.40
▸ KDM4E B2RXH2 6/20 0.40
▸ NPC1 O15118 6/20 0.40
▸ ALDH1A1 P00352 5/20 0.40
▸ MEN1 O00255 4/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ POLB P06746 3/20 0.40
▸ GAA P10253 3/20 0.40
▸ GFER P55789 1/20 0.40
▸ HPGD P15428 4/20 0.39
▸ STAT1 P42224 1/20 0.39
▸ CTDSP1 Q9GZU7 1/20 0.39
▸ APP P05067 2/20 0.38
▸ MMP9 P14780 1/20 0.38
▸ MMP8 P22894 1/20 0.38
▸ SMN1; SMN2 Q16637 6/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23473850 0.94 KDM4E (0.39) MAPTRAB9ANFKB1NFKB2RELA
SCHEMBL23473645 0.91 KDM4E (0.45) MAPTRAB9ANFKB1NFKB2RELA
SCHEMBL22912396 0.90 MAPT (0.45) MAPTRAB9ANFKB1NFKB2RELA
SCHEMBL22912395 0.89 MAPT (0.46) MAPTRAB9ANFKB1NFKB2RELA
SCHEMBL22177861 0.88 MAPT (0.46) MAPTRAB9ANFKB1NFKB2RELA
SCHEMBL23473658 0.87 PTPRF (0.43) MAPTRAB9ANFKB1NFKB2RELA
SCHEMBL22178378 0.87 APP (0.44) MAPTRAB9ANFKB1NFKB2RELA
SCHEMBL23473670 0.87 KDM4E (0.39) MAPTRAB9ANFKB1NFKB2RELA
SCHEMBL22178375 0.87 APP (0.44) MAPTRAB9ANFKB1NFKB2RELA
SCHEMBL23118196 0.87 MAPT (0.46) MAPTRAB9ANFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11725138-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. 2023-08-15 — — US disclosed
US-11725138-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. 2023-08-15 — — US disclosed
US-20210175433-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2021-06-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11725138-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same OR10J3, ICOSLG, TRPM4 MAPT 1106/4885RAB9A 1319/4885NFKB1 2883/4885
US-20210175433-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME OR10J3, ICOSLG, TRPM4 MAPT 1106/4885RAB9A 1319/4885NFKB1 2883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback